Global Placenta Market Size By Type (Porcine, Equine), By Application (Pharmaceuticals, Cosmetics), By Region, And Segment Forecasts, 2023 to 2032

The Global Placenta Market was valued at USD 610 million in 2023 and is projected to reach USD 1.08 billion by 2031, growing at a CAGR of 7.3% during the forecast period of 2023–2031. The growth is primarily driven by the increasing utilization of placental extracts in pharmaceuticals, cosmetics, and regenerative medicine. The placenta, rich in bioactive components, is gaining traction as a critical ingredient in wound healing, anti-aging therapies, and hormone treatments. Rising awareness about its therapeutic benefits, advancements in extraction techniques, and growing demand for biologically active ingredients in the wellness sector are expected to fuel market expansion.

Drivers:

1. Growing Demand in Regenerative Medicine:

Placental tissues are increasingly being used in regenerative therapies due to their anti-inflammatory, anti-scarring, and healing properties. Their role in stem cell therapy, orthopedics, and chronic wound care is boosting demand across the medical field.

2. Expanding Cosmetic and Skincare Industry:

Placental extracts are widely used in cosmetic products for their anti-aging, skin rejuvenation, and collagen-boosting effects. With the beauty industry emphasizing natural and bioactive formulations, the placenta has become a premium ingredient.

3. Advancements in Placenta-Derived Products:

Ongoing research and improved techniques in the extraction and purification of placental components are leading to the development of new, effective products for both pharmaceutical and cosmetic applications.

Restraints:

1. Ethical and Cultural Concerns:

The sourcing and use of human or animal placenta raise ethical and cultural concerns, potentially affecting consumer acceptance and limiting growth in conservative regions.

2. Regulatory Challenges:

Strict regulations regarding the use of human or animal tissues in products, especially in pharmaceuticals and cosmetics, can slow down product development and market entry.

Opportunity:

1. Rising Popularity of Personalized Medicine:

The increasing trend toward personalized healthcare and the use of biologics opens new avenues for placenta-derived therapies, particularly in cell-based treatments and immune modulation.

2. Market Expansion in Emerging Economies:

Rapidly growing healthcare infrastructure and increasing consumer spending on wellness and cosmetic products in Asia-Pacific and Latin America provide significant growth opportunities for placenta-based products.

Market by System Type Insights:

Based on system type, the placental extract segment dominated the market in 2023. These extracts are extensively used in both medical and cosmetic formulations due to their rich content of growth factors, peptides, and enzymes. They are popular in topical anti-aging creams, serums, and injectable therapies for wound healing and skin regeneration. This segment is expected to maintain its lead, supported by ongoing innovations and clinical endorsements.

Market by End-Use Insights:

In terms of end-use, the pharmaceutical sector accounted for the largest market share in 2023. Applications such as chronic wound care, hormone therapy, and anti-inflammatory treatments are driving demand. The cosmetics and personal care segment is also witnessing robust growth, especially in Asia, with an increasing number of placenta-infused skincare and haircare products entering the market.

Market by Regional Insights:

Asia-Pacific held the largest market share in 2023, primarily due to historical usage, strong cultural acceptance, and a thriving cosmetics industry in countries like Japan, South Korea, and China. North America is emerging as a high-growth region, driven by the adoption of regenerative therapies and rising demand for advanced skincare solutions. Europe maintains a significant presence, although growth is moderated by regulatory scrutiny and consumer perception.

Competitive Scenario:

Key players in the Global Placenta Market include Japan Bio Products Co., Ltd., CJT Company Limited, Biofac A/S, Placenta Sciences, VIVITA, and Bioplant. These companies are focusing on technological innovation, ethical sourcing strategies, and partnerships with research institutions to develop next-generation placental therapies and cosmetic formulations.

Scope of Work – Global Placenta Market

Key Market Developments:

2023: Japan Bio Products Co. Ltd. launched a new injectable placental extract for chronic wound care, gaining approval in several Asia-Pacific markets.

2024: VIVITA introduced a vegan-certified placenta-based cream using plant-based analogs, expanding its global footprint in ethical skincare.

2025: Biofac A/S announced collaboration with a biotech startup to develop synthetic placenta mimetics for pharmaceutical use.

FAQs:

1) What is the current market size of the Global Placenta Market?

The Global Placenta Market was valued at USD 610 million in 2023.

2) What is the major growth driver of the Global Placenta Market?

The key growth driver is the increasing use of placenta in regenerative medicine and advanced skincare applications.

3) Which is the largest region during the forecast period in the Global Placenta Market?

Asia-Pacific is expected to remain the dominant region due to cultural acceptance and a mature cosmetic industry.

4) Which segment accounted for the largest market share in the Global Placenta Market?

The placental extract segment held the largest share in 2023 due to its widespread application in pharmaceutical and cosmetic products.

5) Who are the key market players in the Global Placenta Market?

Major companies include Japan Bio Products Co., Ltd., CJT Company Limited, Biofac A/S, Placenta Sciences, VIVITA, and Bioplant.